The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collabor
Improving Quality and Value of Multiple Sclerosis Care at the Microsystem Level: The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Quality Improvement
What it measured
Main measures
Disease modifying therapy utilization
every 12 weeks for a period of 36 months
Other measures (25)
Clinical outcome for Depression
every 12 weeks for a period of 36 months
Mood and sleepQuality of life (reported by participants)Clinic Outcome for Anxiety
every 12 weeks for a period of 36 months
Mood and sleepQuality of life (reported by participants)Clinic Outcomes on Cognitive Function
every 12 weeks for a period of 36 months
Thinking and memoryQuality of life (reported by participants)Clinic Outcomes on mobility
every 12 weeks for a period of 36 months
Walking and mobilityQuality of life (reported by participants)Clinic Outcomes on fine motor skills and activities of daily living
every 12 weeks for a period of 36 months
Arm and hand functionQuality of life (reported by participants)Clinic Outcomes on stigma associated with MS
every 12 weeks for a period of 36 months
Quality of life (reported by participants)Clinic Outcomes on ability to participate in social roles and activities
every 12 weeks for a period of 36 months
Quality of life (reported by participants)Clinic Outcomes on satisfaction with social roles and activities
every 12 weeks for a period of 36 months
Quality of life (reported by participants)Clinic Outcomes for sleep disturbance
every 12 weeks for a period of 36 months
Mood and sleepQuality of life (reported by participants)Clinic Outcomes for communication
every 12 weeks for a period of 36 months
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.
Exclusion criteria
* Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.
Loading reviews and guidelines…
History
Started
Jul 2017
Main results due
Jun 2020
Finished
Dec 2020